Jin Hui, Aiyer Aparna, Su Jingmei, Borgstrom Per, Stupack Dwayne, Friedlander Martin, Varner Judy
Moores UCSD Cancer Center, University of California, San Diego, La Jolla, California 92093-0819, USA.
J Clin Invest. 2006 Mar;116(3):652-62. doi: 10.1172/JCI24751. Epub 2006 Feb 23.
CD34+ bone marrow-derived progenitor cells contribute to tissue repair by differentiating into endothelial cells, vascular smooth muscle cells, hematopoietic cells, and possibly other cell types. However, the mechanisms by which circulating progenitor cells home to remodeling tissues remain unclear. Here we show that integrin alpha4beta1 (VLA-4) promotes the homing of circulating progenitor cells to the alpha4beta1 ligands VCAM and cellular fibronectin, which are expressed on actively remodeling neovasculature. Progenitor cells, which express integrin alpha4beta1, homed to sites of active tumor neovascularization but not to normal nonimmune tissues. Antagonists of integrin alpha4beta1, but not other integrins, blocked the adhesion of these cells to endothelia in vitro and in vivo as well as their homing to neovasculature and outgrowth into differentiated cell types. These studies describe an adhesion event that facilitates the homing of progenitor cells to the neovasculature.
CD34+骨髓来源的祖细胞通过分化为内皮细胞、血管平滑肌细胞、造血细胞以及可能的其他细胞类型来促进组织修复。然而,循环祖细胞归巢至重塑组织的机制仍不清楚。在此我们表明,整合素α4β1(VLA-4)促进循环祖细胞归巢至α4β1配体血管细胞黏附分子(VCAM)和细胞纤连蛋白,这些配体在活跃重塑的新生血管上表达。表达整合素α4β1的祖细胞归巢至活跃的肿瘤新生血管部位,但不归巢至正常非免疫组织。整合素α4β1的拮抗剂,而非其他整合素的拮抗剂,在体外和体内均阻断了这些细胞与内皮细胞的黏附以及它们归巢至新生血管并分化为不同细胞类型的过程。这些研究描述了一种促进祖细胞归巢至新生血管的黏附事件。